Leaky gut, tight junctions, and amucosal biologies drive passions at Alba Therapeutics.
The biopharmaceutical company will develop a drug for those who suffer from Celiac?s Disease ?an allergy to gluten-containing grains that attacks the small intestine. So far, the only “cure” is total elimination of gluten from one?s diet.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.